Estrada VJ, Mejía HJC, Garza GJG

Language: Spanish
References: 11
Page: 6-15
PDF size: 189.20 Kb.

ABSTRACT

Objective: Although diacerein was introduced in 1994 in other countries, the current literature has not established a defined role for chondroprotectives according to Cochrane. The aim of the study is to demonstrate the effects of diacerein in osteoarthritis patients based on functional assessment with analog pain scale, index Knee Society and Western Ontario and McMaster Universities Arthritis index (WOMAC index). We tested the null hypothesis of no difference between treatment with and without diacerein in terms of pain relief and improved function. Methods: 100 patients with osteoarthritis of the knee were randomly divided into two groups, with group 1 patients with only anti-inflammatory treatment and group 2 patients with inflammatory plus diacerein. They were followed for 6 months. WOMAC index, the modified Knee Society Score and visual analog scale were applied. Results: Both groups showed improvement from the initial assessment on WOMAC index but significant difference at 6 months for the 3 scores. Women showed a significant improvement in only 1 of 6 possible combination of evolution-treatment (WOMAC index), while men showed significant improvement in 5 out of 6 (all measurements except the Knee Society Score). Conclusion: Differences between patients with and without diacerein with respect to pain relief and improved function at 6 months follow up. Women showed lower response to treatment compared to men in the 3 evaluation scales.

REFERENCES

1. National Center for Health Statistics. National hospital discharge surveys, data tapes. Facts about Total Hip and Total Knee Replacement. Data extracted and analyzed by the American Academy of Orthopaedic Surgeons, Department of Research and Scientific Affairs. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1995.

2. Moore AR, Greenslade KJ, Alam CA, Willoughby DA. Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. Osteoarthritis Cartilage. 1998; 6 (1): 19-23.

3. Yaron M, Shirazi I, Yaron I. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage. 1999; 7 (3): 272-280.

4. Pujol JP, Felisaz N, Boumediene K, Ghayor C, Herrouin JF, et al. Effects of diacerein on biosynthesis activities of chondrocytes in culture. Biorheology. 2000; 37: 177-184.

5. Saleh TS, Calixto JB, Medeiros YS. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999; 20 (8): 949-956.

6. Pelletier JP, Mineau F, Fernandes JC, Duval N, Martel-Pelletier J. Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol. 1998; 25 (12): 2417-2424.

7. Mathieu P. Interleukin 1: Its role, its dosage, the difficulties in advances in arthritis. Results of a “pilot” study with diacerheine (ART 50) in gonarthrosis. Rev Prat. 1999; Suppl 13: S15-8.

8. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum. 2000; 43 (10): 2339-2348.

9. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M, et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in oa of the hip. Arthritis Rheum. 2001; 44 (11): 2539-2547.

10. Fagnani F, Bouvenot G, Valat JP, Bardin T, Berdah L, Lafuma A. Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritis. Pharmacoeconomics. 1998; 13 (1 Pt 2): 135-146.

11. Lequesne M, Berdah L, Gerentes I. Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis. Rev Prat. 1998; 48: S31-35.